Theodoridis A, Vagena A, Sivenas C, Capetanakis J
Curr Med Res Opin. 1979;5(10):766-71. doi: 10.1185/03007997909109011.
Halcinonide-neomycin-amphotericin (HNA) cream was evaluated in the treatment of cutaneous candidiasis and inflammatory dermatoses. The anti-candidal properties of HNA were assessed in a parallel comparison with iodochlorhydroxyquin-hydrocortisone (I-HC) as the control drug. The overall therapeutic response with HNA was excellent in 38 (95%) of 40 patients as compared to 17 (43%) of 40 treated with I-HC. In 50 patients treated for psoriasis, eczematous dermatitis, or neurodermatitis, HNA was evaluated in a paired comparison with hydrocortisone (HC). The overall therapeutic response with HNA was excellent in 36 (72%) patients as compared to 18 (36%) with HC. There were no adverse reactions with HNA or the control drugs.
哈西奈德-新霉素-两性霉素（HNA）乳膏用于治疗皮肤念珠菌病和炎性皮肤病。将HNA的抗念珠菌特性与作为对照药物的碘氯羟喹-氢化可的松（I-HC）进行平行比较评估。40例患者中，使用HNA的总体治疗反应极佳的有38例（95%），而使用I-HC治疗的40例中仅有17例（43%）。在50例接受银屑病、湿疹性皮炎或神经性皮炎治疗的患者中，将HNA与氢化可的松（HC）进行配对比较评估。使用HNA的总体治疗反应极佳的患者有36例（72%），而使用HC的为18例（36%）。HNA或对照药物均未出现不良反应。
